Eight participants were reported to produce antibodies to COVID-19, in a vaccine trial by Moderna Inc. Image: REUTERS/Brian Snyder
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
License and Republishing
The views expressed in this article are those of the author alone and not the World Economic Forum.
The Agenda Weekly
A weekly update of the most important issues driving the global agenda